LivaNova PLC announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Memo 4D semi-rigid mitral annuloplasty ring. The company also confirmed the first implantation of the device.

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of the In.Pact Admiral Drug-Coated Balloon (DCB) to treat long superficial femoral artery (SFA) lesions in patients with peripheral artery disease (PAD).

A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the arteries of the heart. While high saturated fat levels in red meat have long been known to contribute to heart disease for people in general, the new finding suggests that a subgroup of the population may be at heightened risk for a different reason – a food allergen. The study, which is supported by the National Heart, Lung and Blood Institute, part of the National Institutes of Health, appears in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), a peer-reviewed journal of the American Heart Association.

The U.S. Food and Drug Administration (FDA) released the following two draft guidance documents: Coronary, Peripheral, and Neurovascular Guidewires - Performance Tests and Recommended Labeling; and Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings - Labeling Considerations.

This is a 360 degree image from the Canon Aquilion One 320-slice computed tomography (CT) system installed at Northwestern Medicine Central DuPage Hospital in Winfield, Ill.. The system has a large anatomical imaging area so it is able to capture the entire heart in one rotation instead of stitching images together from different heart beats.  

Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to repair a leaky mitral heart valve.

Medication management platform Medisafe released data showing that, on average, hypertensive patients increase their prescription refills by almost 10 percent after they start using the company's mobile app.

The thought of losing up to $14 a week along with personalized goal setting may have motivated ischemic heart disease patients to increase their exercise, according to a new clinical trial published in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable recommendation on its premarket approval application from a key U.S. Food and Drug Administration (FDA) panel. The FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee voted 11 to 4 in favor of the benefits of the device.

Subscribe Now